Categories: Wire Stories

Bank of New Zealand and Israel�s OurCrowd Announce Tech Investment Alliance

Partnership to further expand New Zealand-Israel startup collaboration

AUCKLAND, New Zealand & JERUSALEM–(BUSINESS WIRE)–OurCrowd, one of the world�s largest global venture investing platforms, and Bank of New Zealand (BNZ) today announced an innovative collaboration that will provide BNZ customers with direct access to exclusive OurCrowd cutting-edge companies, venture funds and its domestic and global networking opportunities and events.

BNZ GM Private Bank, Charlotte Noble-Beasley, said: “We’re excited about this first of its kind partnership in New Zealand because it will provide direct access for BNZ high net worth clients to one of the world’s most active global investment platforms. Being able to leverage OurCrowd’s global network will help our high net worth clients access opportunities with emerging tech companies and have the ability to further diversify their investment portfolios.”

Noble-Beasley says the partnership also provides more opportunities for New Zealand start-ups.

“BNZ backs New Zealand tech, we understand the industries and the companies in it, and we’re excited to be able to offer another avenue and service for our tech company customers with OurCrowd,” says Noble-Beasley.

In December 2019, OurCrowd won the tender to join a consortium to launch an Auckland Agritech incubator Sprout, which is sponsored by the NZ government’s Callaghan Innovation. Led by CEO Gil Meron, other partners in this incubator include US-based leading Agtech Venture group Finistere Ventures and New Zealand’s food giant Fonterra.

OurCrowd CEO, Jon Medved, said: “BNZ is one of New Zealand’s most respected financial institutions, so we’re delighted to provide its high net worth clients unparalleled access to invest and engage in leading global emerging companies. OurCrowd has already committed to an incubator in New Zealand and this new collaboration marks another important milestone in providing support to start-ups in New Zealand as well as delivering broad investor access to innovative companies tackling global challenges.”

OurCrowd portfolio company CropX, which was originally founded in New Zealand, recently acquired New Zealand-based Regen. CropX has also opened an Australian office, as well as completing a one-year experiment in the New South Wales regional city in Wagga Wagga, which demonstrated significant water savings and crop yield increase for farmers using its cloud-connected ground sensors.

OurCrowd Managing Partner, Australia and Asia, Dan Bennett, said: “We established the OurCrowd office in Australia in 2014 and have shortly thereafter been providing our friends across the Tasman deep access to our global investment networks. New Zealand is a strategically important market for us and this new collaboration with BNZ will be a real win-win to support providing BNZ high net worth clients with strong global connectivity.”

In March 2020, the New Zealand government signed an innovation and R&D agreement with Israel.

END

About Bank of New Zealand (BNZ): Bank of New Zealand was founded in 1861 and has been an integral part of New Zealand life ever since. Today the bank employs over 5,000 people in New Zealand; works with Personal, Business, Agri and Private Wealth HNW clients; and has 180 branches and Partners’? Centres across NZ.

About OurCrowd: OurCrowd is a global venture investment platform that empowers institutions and individuals to invest and engage in emerging companies. Rated by PitchBook as the most active venture investor in Israel, OurCrowd vets and selects companies, invests its capital, and provides its global network with unparalleled access to co-invest and contribute connections, talent and deal flow. OurCrowd builds value for its portfolio companies throughout their lifecycles, providing mentorship, recruiting industry advisors, navigating follow-on rounds and creating growth opportunities through its network of multinational partnerships. With NZD $2.2 billion of committed funding, and investments in more than 220 portfolio companies and 22 venture funds, OurCrowd offers access to its membership of almost 60,000 individual accredited and institutional investors, family offices, and venture capital partners from over 183 countries to invest alongside, at the same terms. OurCrowd’s portfolio is diversified across sectors and stages, ranging from seed and series A through late stage and pre-IPO firms. OurCrowd portfolio companies have been acquired by some of the most prestigious brands in the world, including Microsoft, Uber, Canon, Oracle, Nike, and Intel. To register and get involved, visit www.ourcrowd.com.

Contacts

PRESS:

BNZ: Sam Durbin +64 27 529 4342

E: sam_durbin@bnz.co.nz

OurCrowd: Leah Stern, Dir. Of Communications / Europe: +44 747 0196826

E: leah@ourcrowd.com

Alex

Recent Posts

Zhengzhou: Interactive Exhibitions on the International Museum Day

ZHENGZHOU, China--(BUSINESS WIRE)--In central China’s Zhengzhou city, visiting museums has become a new trend of…

7 hours ago

Reality TV Star, Mollie Pearce, Backs Campaign to Tackle Inequalities in Condition That Impacts Millions of People Globally

Mollie Pearce, star of the UK reality TV show ‘The Traitors’ who was diagnosed with…

17 hours ago

Quality Building Award 2024 Unveils Finalist List

QBA 2024 Announces 35 Finalists Competing for Hong Kong's Highest Honour in the Building Industry…

2 days ago

UXLINK Tops RootData’s Latest X Hot Items List and DappRadar Social Apps List

SINGAPORE - Media OutReach Newswire - 17 May 2024 - UXLINK, the Web3 social platform…

2 days ago

Australia Construction Industry Report 2024: Growth to Slow to 2% in Real-terms this Year Following 9% Growth in 2023 – Forecasts to 2028 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Australia Construction Market Size, Trend Analysis by Sector, Competitive Landscape and Forecast to…

2 days ago

Connecting the Dots of ANKTIVA’s Triangle Offense: A Deep Dive with Dr. Patrick Soon-Shiong and Dr. Ashish Kamat in a Three-Part UroToday Podcast

Three-part podcast interview features The mechanism of action of ANKTIVA® activating NK cells, Killer T…

2 days ago